MICHELLE MWENDWA NGUU

• Provide national leadership in oncology health products and technologies, aligning with the National Cancer Control Strategy and access priorities.
• Partner with the Ministry of Health (MoH), Social Health Authority (SHA), Pharmacy and Poisons Board (PPB), and KEMSA to co-develop oncology procurement strategies, biosimilar guidance, and formulary management frameworks.
• Led the national technical working team of KEMSA officials and oncology pharmacists from referral hospitals in the selection and quantification of oncology health products, ensuring alignment with treatment guidelines and projected patient needs.
• Served as Technical Lead in oncology product selection at KEMSA (Aug 2025) following a Budget Impact Analysis (BIA) that enabled inclusion of 15 Pfizer Accord oncology molecules, projected to deliver 40–60% annual cost savings.
• Conducted multiple BIAs comparing Pfizer Access Program, KEMSA, and KNH oncology prices, providing actionable insights to guide procurement and enhance affordability.

Key Achievements.

• Spearheaded oncology procurement reform by aligning national product selection with clinical guidelines, improving formulary efficiency, and access.
• Delivered projected 40–60% annual cost savings through BIAs that informed uptake of biosimilars and innovative therapies.
• Strengthened institutional capacity by training facility teams on demand forecasting and portfolio management, improving medicine availability across cancer centers.
• Positioned Kenya’s oncology procurement strategy as a regional benchmark for access and sustainability.

• Partnered with WHO, Pfizer, and MoH experts to co-develop an oncology formulary gap analysis, identifying 14 high-priority molecules missing in KEMSA procurement.
• Performed BIAs comparing Pfizer Access Program, KEMSA, and KNH oncology prices, generating insights that informed procurement decisions and improved patient affordability.
• Supported multi-stakeholder dialogues on cancer control, access, and procurement, enhancing national access frameworks.

Key Achievements

• Developed Kenya’s first oncology formulary gap analysis, integrating WHO EML 2023 to prioritize high-impact molecules.
• Informed national policy by presenting access and pricing insights to SHA and MoH, strengthening evidence-based decision-making.

• Led national oncology prevention, screening, and early detection programs across 47 counties with county health leadership.
• Partnered with hospitals to expand oncology clinics in underserved regions (Turkana, Samburu), improving equity in access.
• Co-created HPV DNA screening procurement and implementation plans with counties, WHO, and MoH, targeting 3,000 beneficiaries.
• Facilitated training of 90+ county health promotion officers on cancer prevention, early diagnosis, and palliative care.

Key Achievements

• Expanded oncology service lines into remote counties, reducing geographic inequities in access to care.
• Piloted HPV DNA screening aligned with WHO elimination targets, positioning Kenya as a regional leader in prevention programs.
• Strengthened public–private partnerships by negotiating biosimilar uptake, achieving sustainable procurement gains.

• Collaborated with institutional leadership and multidisciplinary teams to streamline oncology workflows and improve care coordination.
• Organized and facilitated MDTs, aligning case discussions with clinical guidelines for timely and consistent treatment plans.

Key Achievements

• Co-developed structured oncology workflows that improved clinic efficiency and patient throughput.
• Enhanced patient access through the rollout of standardized cancer screening protocols.

• Engaged leadership and clinical teams to co-design service line restructuring, increasing patient throughput by 60% within 12 months.
• Implemented cost-control measures and optimized procurement, reducing operational expenditure by 15%.
• Strengthened quality systems and compliance, positioning the centre as a model outpatient facility.
• Key Achievements
• Achieved early financial break-even by optimizing budgeting and cost recovery models.
• Enhanced reporting accuracy by 25% following EHR system optimization.

• Managed acute and complex emergency cases in a high-volume private hospital, coordinating multidisciplinary care teams.
• Contributed to optimizing triage and emergency referral systems, improving patient stabilization outcomes.